FluroTech (TSXV:TEST), (“FluroTech” or the “Company”) is pleased to announce that it has finalized the engineering & design of its flagship product, CompleTest™, and engaged a third party manufacturer to produce the first commercial production run of the housing for the CompleTest™ Series 1 device.

The desktop device will commence commercial production July 2018 and is expected to be available for sale in Canada by October 2018, along with the first of a series of test kits that will be made available sequentially to the Cannabis industry over the next year and a half. Sales to international markets are expected in the first half of 2019.


“Over a decade of research has gone into the development of the CompleTest™ devices and test kits,” stated Dr. Elmar Prenner, Chief Technology Officer. “We believe this disruptive technology is a step change when compared to conventional high-performance liquid chromatography and mass spectroscopy, which require trained lab technicians to perform experiments and interpret complex sets of data.” Dr. Prenner explained that because the CompleTest™ allows users to obtain highly accurate results within minutes rather than waiting days or weeks for results from third party labs, it may allow cannabis producing companies to move from a compliance mindset to optimizing production by providing them tools to produce the highest quality products for their consumers.

Cross lab variability and a desire to understand one’s product before sending it for third party certification has led Canadian licensed producers and international growers to express a keen interest to be able to carry out in-house quality control and THC/CBD potency optimization.

“Opportunities for effective cannabis testing technology continue to expand with the recent legalization of recreational cannabis in Canada,” explained Danny Dalla-Longa, Chief Executive Officer. “CompleTest™ will fill a gap in the testing market, enabling growers, retailers and regulators to employ a user friendly, in-house option to affordably test cannabis, resulting in fast, accurate and repeatable results.”

About CompleTest

CompleTest™ is FluroTech’s flagship brand and product line. CompleTest™ is a portable, cost-effective, state-of- the-art cannabis testing device, able to provide quick, accurate and consistent testing results. It’s designed for cultivators, dispensaries and anyone with a vested interest in consumer safety to test the quality and safety of their cannabis products and to optimize potency yield.

About FluroTech (TSXV: TEST)

FluroTech is a technology and marketing company whose core business is focused on the commercialization of new technologies in the cannabis industry. FluroTech’s proprietary spectroscopy-based technology allows for the testing and identification of organic and inorganic compounds contained within biological samples derived from cannabis plants. Using the technology that was developed at the University of Calgary in conjunction with the University of Alberta, FluroTech has developed a two-part solution comprising an instrument called the CompleTest™ and consumable testing kits.

To learn more, visit www.FluroTech.com and watch our video.

Contact Information
FluroTech Ltd.
Alistair Ross Technology Centre
Suite 111, 3553-31 Street NW
Calgary, AB T2L 2K7
info@flurotech.com

Danny Dalla-Longa
Chief Executive Officer
403.680.0644
danny@flurotech.com

Prit Singh
IR — Thesis Capital Inc.
905.510.7636
psingh@thesiscapital.ca

Click here to connect with FluroTech (TSXV:TEST) for an Investor Presentation.

Source: www.newsfilecorp.com

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less